VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HYPR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HYPRHyperfine, Inc.
$0.56$46M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HYPR logo

Hyperfine, Inc.

HYPR
NASDAQ · Medical Imaging & Radiation
$0.56
At close - Nov 17, 4:00 PM EST - USD
Market Cap$47M
P/E-2.0x
52W High$1.94
Volume1.16M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q1

Persistent Operating Losses Threaten Capital Sustainability

Hyperfine faces a challenging path to profitability as it struggles to scale its proprietary low-field MRI technology amidst volatile revenue growth and significant operational overhead.

GrowthMixed
ProfitabilityNegative
ValuationReview
TechnicalsWeak
Explore valuation models
MARKET ACTION

HYPR price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

3/12 Beats

EPS beat 3 of last 12 quarters

02

Valuation risk

-109% Peers

P/E is 109% below peer median

03

Market leadership

RS 16 · Lag

Laggard (Underperforming 84% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Feb 9

Market performance

Price History →

Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
HYPR-42.04%
S&P 500 (^GSPC)+7.21%
1-Year Return
HYPR-49.86%
S&P 500 (^GSPC)+10.03%
3-Year Return
HYPR-54.71%
S&P 500 (^GSPC)+58.71%
5-Year Return
HYPR-94.36%
S&P 500 (^GSPC)+49.93%

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$14M+5.2% YoY
Net income FY25
-$36M+12.6% YoY
Free cash flow FY25
-$29M+25.6% YoY
Operating margin FY25
-273.4%+61.9 pts YoY
ROIC (FY25)-310.8%
Avg ROIC 5Y-1701.7%
ROE (TTM)-82.9%
Piotroski Score3 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate3/12 (25%)
Revenue Beat Rate6/12 (50%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 9, 2026
-$0.07+15.2%
vs -$0.08
$6M+2.1%
vs $6M
Q3 2026
Aug 6, 2026
-$0.09+0.0%
vs -$0.09
$4M-5.6%
vs $4M
Q2 2026
May 12, 2026
-$0.09+0.0%
vs -$0.09
$4M+10.3%
vs $4M
Q2 2026
Mar 18, 2026
-$0.08+0.0%
vs -$0.08
$5M+2.7%
vs $5M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Seeking Alpha·Nov 10, 2026
Hyperfine, Inc. (HYPR) Q3 2026 Earnings Call Transcript

Hyperfine, Inc. (HYPR) Q3 2026 Earnings Call Transcript

MarketBeat·Nov 9, 2026
What Hyperfine (HYPR) Said on Its Q3 Earnings Call

Hyperfine NASDAQ: HYPR reported record third-quarter revenue and gross margin, while narrowing its operating loss and reducing cash burn as sales of its portable brain MRI system increased across its U.S. and international markets.

Business Wire·Nov 9, 2026
Hyperfine, Inc. Reports Third Quarter 2026 Financial Results

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced third quarter 2026 financial results and provided a business update. “Q3 2026 marked the beginning of a new trajectory for Hyperfine. We delivered record revenue, gross profit, and gross margin, and for the first time quarterly revenue exceeded net.

Defense World·Nov 6, 2026
Sysmex (OTCMKTS:SSMXY) vs. Hyperfine (NASDAQ:HYPR) Critical Analysis

Hyperfine (NASDAQ: HYPR - Get Free Report) and Sysmex (OTCMKTS:SSMXY - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability and dividends. Profitability This table compares Hyperfine and Sysmex's net margins, return

Filtered for Hyperfine, Inc.More Headlines
04

Compare before deciding

Benchmark HYPR against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Hyperfine, Inc. (HYPR)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
HYPR logoHYPRHyperfine, Inc.Current
$0.56$47.3M-2.005.22%-156.42%-82.89%—
PRCT logoPRCTPROCEPT BioRobotics Corporation
$23.78$1.35B-11.8737.22%-32.6%-33.23%—
NVCR logoNVCRNovocure Ltd
$11.14$1.29B-10.698.28%-16.78%-35.81%—
INVA logoINVAInnoviva, Inc.
$18.30$1.35B6.8218.52%43.79%15.84%—
AEYE logoAEYEAudioEye, Inc.
$11.06$138.18M-47.1814.52%-7.12%-74.71%—
GEHC logoGEHCGE HealthCare Technologies Inc.
$81.84$36.97B21.064.84%8.54%15.87%0.17%

Compare HYPR vs Peers

Hyperfine, Inc. (HYPR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PRCT

Most directly comparable listed peer for HYPR.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare HYPR against a more recognizable public peer.

Peer Set

Compare Top 5

vs PRCT, NVCR, INVA, AEYE

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

HYPR SEC Filings & Documents

Hyperfine, Inc. (HYPR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Nov 9, 2026·SEC

Material company update

Aug 6, 2026·SEC

Material company update

May 21, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 18, 2026·SEC

FY 2025

Mar 17, 2025·SEC

FY 2024

Mar 22, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Nov 9, 2026·SEC

FY 2026

Aug 6, 2026·SEC

FY 2026

May 12, 2026·SEC

Get notified when HYPR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

HYPR Frequently Asked Questions

Hyperfine, Inc. (HYPR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Hyperfine, Inc.'s revenue?

Hyperfine, Inc. (HYPR) reported $19.1M in revenue over the trailing twelve months. Revenue was $13.6M in fiscal year 2025.

How fast is Hyperfine, Inc. growing?

Hyperfine, Inc. (HYPR) grew revenue by 80.0% over the trailing twelve months, compared with the twelve months before.

Is HYPR profitable?

No. Hyperfine, Inc. (HYPR) reported a net loss of $29.8M over the trailing twelve months.

Dividend & Returns
What is HYPR's return on equity?

Hyperfine, Inc. (HYPR) had a return on equity (ROE) of -82.9% over the trailing twelve months. A negative ROE means the company lost money over the period.

What is Hyperfine, Inc.'s free cash flow?

Hyperfine, Inc. (HYPR) had negative free cash flow of $27.9M over the trailing twelve months.

What if you invested $1,000 in HYPR back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →